Effectiveness of the ECHOs Approach for Patients With Eating Disorders and Their Carers

Overview

Family therapy is considered an empirically supported treatment approach for adolescents and adults with eating disorders. One family based approach, Expert Carers Helping Others (ECHO) is based on evidence that suggests family environment, e.g., carer criticism, can influence an individual's eating disorder symptoms. ECHO aims to improve carer coping, reduce expressed emotion and manage eating disorder symptoms, and has been associated with reduced carer distress, caregiver burden, and an increase in general well being. The current pilot study seeks to evaluate a new condensed version of the ECHO intervention that is delivered entirely in a 2 ½ hour self-help DVD format (ECHOs). Sixty patients and their carers will be recruited from the Capital Health Eating Disorders Service and randomized into either a treatment as usual group (TAU) or a TAU+ECHOs group. Both carers and patients will be assessed along a variety of dimensions including psychiatric symptoms, family functioning, and carer and patient collaboration, at pre-intervention, four weeks later at post-intervention, and then three-months post-intervention. ANOVAs will be used to compare the primary outcomes between the two groups over time. This pilot study will be the first evaluation of ECHOs, which may ultimately boost the efficacy of current treatment for adults with eating disorders and reduce carer distress.

Full Title of Study: “Effectiveness of the Expert Carers Helping Others (ECHOs) Approach for Patients With Eating Disorders and Their Carers”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Single (Outcomes Assessor)
  • Study Primary Completion Date: December 2017

Interventions

  • Behavioral: ECHOs plus TAU
    • A self-help DVD that provides information for carers on eating disorders and teaches coping strategies to carers.
  • Behavioral: Treatment as Usual
    • Treatment as Usual at the Eating Disorder Services includes group psychotherapy and skills training, nutritional counselling, and meal support.

Arms, Groups and Cohorts

  • Experimental: Expert Cares Helping Others plus Treatment as Usual
    • The experimental treatment (ECHOs plus TAU) will consist of the standard treatment consisting of group psychotherapy and skills training, nutritional counselling, and meal support, PLUS self-help unguided DVD series for carers, providing education about eating disorders and coping strategies for supporting those living with eating disorders.
  • Active Comparator: Treatment as Usual
    • Treatment as usual (TAU) consists of group psychotherapy and skills training, nutritional counselling, and meal support.

Clinical Trial Outcome Measures

Primary Measures

  • Changes in Carer and Patient Collaboration Scale (CPCS).
    • Time Frame: baseline, 4-weeks post-intervention, 3 months follow-up
    • A scale to assess self efficacy in caregiving, specifically tailored to measure the skills taught in the ECHOs intervention. This scale will assess changes from baseline to post-internvention in caregiver efficacy.
  • Changes in Short Evaluation of Eating Disorders (SEED)
    • Time Frame: baseline, 4-weeks post-intervention, 3 months follow-up
    • This measure will asssess changes in the severity of key anorexic and bulimic symptoms from baseline to post-treatment, and follow-up.

Secondary Measures

  • Depression, Stress and Anxiety Scale (DASS-21)
    • Time Frame: baseline, 4-weeks post-intervention, 3 months follow-up
    • a measure of severity of anxiety, depression and stress pre- to post-treatment
  • The Family Questionnaire (FQ)
    • Time Frame: baseline, 4-weeks post-intervention, 3 months follow-up
    • 20-item self report measure of expressed emotion in carers. Scores are given on a 4-point Likert scale and will measure the levels of expressed emotion from pre-intervention to post-intervention.

Participating in This Clinical Trial

Inclusion Criteria

  • Patients with an ED (AN, BN, EDNOS) according to DSM-V criteria (American Psychiatric Association, 2013) as determined by standard clinical interview completed by team psychiatrist or clinical psychologist. – Patients age of >17y.o. – Carers can include parents/partners/siblings/extended family who provide unpaid help and support. Peers and roommates could also be included in circumstances within which they play a significant role in the person's life and meet the following criteria: – Live with or have regular, current contact with the patient (at least 7 hours/week) throughout the duration of the trial (approximately 6months). – Interact with the patient in some meaningful manner regarding their ED (e.g. provide support, eat meals together, discussions about behaviours). – Consent from patient and at least one carer Exclusion Criteria:

  • ED comorbid with severe psychiatric or physical comorbidity: e.g. current psychotic illness (inc. bipolar disorder), severe alcohol/drug abuse, significant metabolic or gastrointestinal problems (i.e. treatment interfering) as determined by standard clinical interview completed by team psychiatrist or clinical psychologist. – Family in a concurrent treatment trial. – Either patient or carer has insufficient knowledge of English.

Gender Eligibility: All

Minimum Age: 17 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Nova Scotia Health Authority
  • Provider of Information About this Clinical Study
    • Principal Investigator: Aaron Keshen, Psychiatrist – Nova Scotia Health Authority

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.